(Q73699220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

G van Andel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K H Kurth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

209-214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

The development of a method for assessing the quality of life of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

An approach to evaluation of sexual problems in the cancer patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Prostate cancer patients' utilities for health states: how it looks depends on where you stand.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

A multi-attribute model of prostate cancer patient's preferences for health states

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Defining an international research agenda for quality of life in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Fatigue in patients with prostate cancer receiving hormone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900208-2

7 January 2021

10.1016/S0302-2838(03)00208-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12875940%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference